Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription

Articles published in Am J Surg Pathol

Retrieve available abstracts of 19 articles:
HTML format

Single Articles

    December 2022
  1. ORDULU Z, Mino-Kenudson M, Young RH, Van de Vijver K, et al
    Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
    Am J Surg Pathol. 2022;46:1670-1681.
    PubMed     Abstract available

    September 2022
  2. HOPKINS MR, Palsgrove DN, Ronnett BM, Vang R, et al
    Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals TP53 and CDKN2A comutations: A Clinicopathologic Analysis With Re-evaluation of Diagnostic Criteria.
    Am J Surg Pathol. 2022 Sep 5. pii: 00000478-990000000-00077.
    PubMed     Abstract available

    August 2022
  3. DEVINS KM, Young RH, Ghioni M, Burandt E, et al
    Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
    Am J Surg Pathol. 2022 Aug 9. pii: 00000478-990000000-00051.
    PubMed     Abstract available

    June 2022
  4. COSTIGAN DC, Nucci MR, Dickson BC, Chang MC, et al
    NTRK-Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Am J Surg Pathol. 2022 Jun 20. pii: 00000478-990000000-00034.
    PubMed     Abstract available

  5. STOLNICU S, Karpathiou G, Guerra E, Mateoiu C, et al
    Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases.
    Am J Surg Pathol. 2022;46:765-773.
    PubMed     Abstract available

    May 2022
  6. KIYOKAWA T, Hoang L, Pesci A, Alvarado-Cabrero I, et al
    Claudin-18 as a Promising Surrogate Marker for Endocervical Gastric-type Carcinoma.
    Am J Surg Pathol. 2022;46:628-636.
    PubMed     Abstract available

  7. WANG Y, Chang RJ, Luo RZ, Yu J, et al
    Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
    Am J Surg Pathol. 2022;46:713-724.
    PubMed     Abstract available

    April 2022
  8. REGAUER S, Reich O, Kashofer K
    Cervical Precancers Originate From Infected Proliferating Reserve Cells: A Comparative Histologic and Genetic Study of Thin and Thick High-grade Squamous Intraepithelial Lesions.
    Am J Surg Pathol. 2022;46:519-527.
    PubMed     Abstract available

    March 2022
  9. ZHOU F, Chen H, Li M, Strickland AL, et al
    The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma.
    Am J Surg Pathol. 2022;46:300-308.
    PubMed     Abstract available

    February 2022
  10. REGAUER S, Reich O, Kashofer K
    HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
    Am J Surg Pathol. 2022;46:147-158.
    PubMed     Abstract available

    December 2021
  11. FEINBERG J, Hodgson A, Abu-Rustum NR, Long Roche K, et al
    Clinical, Morphologic, and Molecular Features Associated With Ovarian Metastases From Pattern A Endocervical Adenocarcinomas.
    Am J Surg Pathol. 2021 Dec 10. pii: 00000478-900000000-97090.
    PubMed     Abstract available

    October 2021
  12. WRIGHT TC JR, Stoler MH, Ferenczy A, Ranger-Moore J, et al
    The CERTAIN Study Results: Adjunctive p16 Immunohistochemistry Use in Cervical Biopsies According to LAST Criteria.
    Am J Surg Pathol. 2021;45:1348-1356.
    PubMed     Abstract available

    June 2021
  13. RIVERA-COLON G, Chen H, Molberg K, Niu S, et al
    PD-L1 Expression in Endocervical Adenocarcinoma: Correlation With Patterns of Tumor Invasion, CD8+ Tumor-infiltrating Lymphocytes, and Clinical Outcomes.
    Am J Surg Pathol. 2021;45:742-752.
    PubMed     Abstract available

    November 2020
  14. PORS J, Segura S, Chiu DS, Almadani N, et al
    Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
    Am J Surg Pathol. 2020 Nov 5. doi: 10.1097/PAS.0000000000001612.
    PubMed     Abstract available

    October 2020
  15. STOLNICU S, Boros M, Segura S, Horn LC, et al
    Invasive Stratified Mucinous Carcinoma (iSMC) of the Cervix Often Presents With High-risk Features That Are Determinants of Poor Outcome: An International Multicenter Study.
    Am J Surg Pathol. 2020;44:1374-1380.
    PubMed     Abstract available

    September 2020
  16. TURASHVILI G, Samore WR, Oliva E, Ioffe O, et al
    Secondary Involvement of the Uterine Cervix by Nongynecologic Neoplasms: A Detailed Clinicopathologic Analysis.
    Am J Surg Pathol. 2020 Sep 8. doi: 10.1097/PAS.0000000000001578.
    PubMed     Abstract available

  17. DIBBERN ME, Bullock TN, Jenkins TM, Duska LR, et al
    Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
    Am J Surg Pathol. 2020;44:1184-1191.
    PubMed     Abstract available

    July 2020
  18. STOLNICU S, Segura S, Parra-Herran C, Horn LC, et al
    Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Cervix: A Study on Morphologic Diversity.
    Am J Surg Pathol. 2020;44:873-880.
    PubMed     Abstract available

    May 2020
  19. ZARE SY, Aisagbonhi O, Hasteh F, Fadare O, et al
    Independent Validation of Tumor Budding Activity and Cell Nest Size as Determinants of Patient Outcome in Squamous Cell Carcinoma of the Uterine Cervix.
    Am J Surg Pathol. 2020 May 22. doi: 10.1097/PAS.0000000000001472.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.